CLINICAL_TRIALS
ClinicalTrials.gov record update
Open-Label Safety Study of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia (LID)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02202551
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:00.636443+00:00
- Published At
- 2020-09-16T00:00:00+00:00
- Record Updated At
- 2020-10-06
- Results Posted At
- 2020-09-16
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Dyskinesia", "Levodopa Induced Dyskinesia (LID)", "Parkinson\u0027s Disease (PD)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-10-06"- protocolSection.identificationModule.nctId
"NCT02202551"- protocolSection.identificationModule.officialTitle
"Open-Label Safety Study of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia (LID)"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-09-16"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.